Q2 2026 13F · SEC CIK 19481
Virtus Investment Advisers, LLC
Mutual fund managerFiled 2026-08-11 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $429.2M
- Reported positions
- 463
- Top holdings a year, 3 yrs
- +8.7%
- Assets under management
- $51.7B
Virtus Investment Advisers, LLC is a mutual fund manager that reported 463 positions worth $429.2M in its Q2 2026 13F, filed 2026-08-11. Its largest holdings were Micron Technology Inc (MU, 0.9%), Datadog Inc (DDOG, 0.8%), Marvell Technology Inc (MRVL, 0.8%). A portfolio copying its top holdings returned 8.7% a year over the last 3 years, against 20.4% for the S&P 500.
Virtus Investment Advisers, LLC holdings largest 50 of 463 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Virtus Investment Advisers, LLC bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- ALNY Alnylam Pharmaceuticals Inc+33.2% shares
- REGN Regeneron Pharmaceuticals+20.1% shares
- GILD Gilead Sciences Inc+14.1% shares
- INCY Incyte Corp+8.7% shares
- AMGN Amgen Inc+6.4% shares
Reduced
- PWR Quanta Svcs Inc-28.6% shares
- AMAT Applied Matls Inc-21.9% shares
- CSCO Cisco Sys Inc-15.3% shares
- HWM Howmet Aerospace Inc-15.3% shares
- ALL Allstate Corp-13.6% shares
- EIX Edison Intl-12.1% shares
- TRV Travelers Companies Inc-12.0% shares
- CINF Cincinnati Finl Corporation-9.5% shares
Left the top 50
- IBRX Immunitybio Incwas 0.8%
- VRTX Vertex Pharmaceuticals Incwas 0.7%
- VRT Vertiv Holdings Cowas 0.7%
- ROST Ross Stores Incwas 0.6%
- DAWN Day One Biopharmaceuticals Incwas 0.6%
- BURL Burlington Storeswas 0.6%
- SLB Slb Limitedwas 0.6%
- LIN Linde PLCwas 0.6%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +9.3% /yr
- S&P 500 +20.1%
- 3 years
- +8.7% /yr
- S&P 500 +20.4%
- 5 years
- +7.5% /yr
- S&P 500 +19.3%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $429.2M | 463 |
| Q1 2026 | $362.5M | 450 |
| Q4 2025 | $367.9M | 461 |
| Q3 2025 | $349.3M | 440 |
| Q2 2025 | $295.8M | 439 |
| Q1 2025 | $362.9M | 470 |
| Q4 2024 | $124.3M | 293 |
| Q3 2024 | $123.8M | 269 |
| Q2 2024 | $110.1M | 253 |
| Q1 2024 | $136.6M | 264 |
| Q4 2023 | $133.5M | 346 |
| Q3 2023 | $147.0M | 242 |
Questions about Virtus Investment Advisers, LLC's portfolio
What stocks does Virtus Investment Advisers, LLC own?
Virtus Investment Advisers, LLC's latest 13F, for Q2 2026 and filed Aug 11, 2026, lists 463 positions worth $429.2M. The largest are Micron Technology Inc (MU) at 0.9%, Datadog Inc (DDOG) at 0.8%, Marvell Technology Inc (MRVL) at 0.8%, Incyte Corp (INCY) at 0.8% and Applied Matls Inc (AMAT) at 0.8%.
What did Virtus Investment Advisers, LLC buy last quarter?
In Q2 2026, Virtus Investment Advisers, LLC added Alnylam Pharmaceuticals Inc (ALNY) (+33.2% shares), Regeneron Pharmaceuticals (REGN) (+20.1% shares) and Gilead Sciences Inc (GILD) (+14.1% shares), compared with its Q1 2026 filing.
What did Virtus Investment Advisers, LLC sell last quarter?
In Q2 2026, Virtus Investment Advisers, LLC cut from its top 50 Immunitybio Inc (IBRX), cut from its top 50 Vertex Pharmaceuticals Inc (VRTX), cut from its top 50 Vertiv Holdings Co (VRT), cut from its top 50 Ross Stores Inc (ROST), cut from its top 50 Day One Biopharmaceuticals Inc (DAWN), Quanta Svcs Inc (PWR) (-28.6% shares), Applied Matls Inc (AMAT) (-21.9% shares) and Cisco Sys Inc (CSCO) (-15.3% shares), compared with its Q1 2026 filing.
How has Virtus Investment Advisers, LLC's portfolio performed?
A portfolio copying Virtus Investment Advisers, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +8.7% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +9.3% against +20.1%. Over 5 years: +7.5% a year against +19.3%.
When is Virtus Investment Advisers, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Virtus Investment Advisers, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Virtus Investment Advisers, LLC manage?
Virtus Investment Advisers, LLC reported $51.7B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $429.2M.